Choong Ang Vaccine Laboratory Co. Ltd (072020) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.053x

Based on the latest financial reports, Choong Ang Vaccine Laboratory Co. Ltd (072020) has a cash flow conversion efficiency ratio of 0.053x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.70 Billion ≈ $3.86 Million USD) by net assets (₩108.11 Billion ≈ $73.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Choong Ang Vaccine Laboratory Co. Ltd stock valuation for the company's overall valuation and market capitalisation.

Choong Ang Vaccine Laboratory Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Choong Ang Vaccine Laboratory Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Choong Ang Vaccine Laboratory Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Choong Ang Vaccine Laboratory Co. Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Choong Ang Vaccine Laboratory Co. Ltd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
ALT Telecom Public Company Limited BK:ALT	-0.053x
TETHYS PETROLEUM LTD F:TP21	0.112x
Aptech Limited NSE:APTECHT	0.008x
Transpaco Ltd JSE:TPC	0.106x
Multifiling Mitra Indonesia JK:MFMI	0.602x
Fiducial Office Solutions PA:SACI	-0.086x
PW Consolidated Bhd KLSE:7134	0.093x
Soma Gold Corp V:SOMA	0.094x

Annual Cash Flow Conversion Efficiency for Choong Ang Vaccine Laboratory Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Choong Ang Vaccine Laboratory Co. Ltd from 2014 to 2025. View 072020 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩105.37 Billion ≈ $71.41 Million	₩7.87 Billion ≈ $5.33 Million	0.075x	-42.10%
2024-12-31	₩103.87 Billion ≈ $70.39 Million	₩13.40 Billion ≈ $9.08 Million	0.129x	+1.35%
2023-12-31	₩99.80 Billion ≈ $67.64 Million	₩12.71 Billion ≈ $8.61 Million	0.127x	+71.24%
2022-12-31	₩95.30 Billion ≈ $64.59 Million	₩7.09 Billion ≈ $4.80 Million	0.074x	-40.02%
2021-12-31	₩92.98 Billion ≈ $63.01 Million	₩11.53 Billion ≈ $7.81 Million	0.124x	+30.51%
2020-12-31	₩87.55 Billion ≈ $59.33 Million	₩8.32 Billion ≈ $5.64 Million	0.095x	-1.15%
2019-12-31	₩86.37 Billion ≈ $58.53 Million	₩8.30 Billion ≈ $5.62 Million	0.096x	+43.06%
2018-12-31	₩85.00 Billion ≈ $57.61 Million	₩5.71 Billion ≈ $3.87 Million	0.067x	-42.55%
2017-12-31	₩64.68 Billion ≈ $43.83 Million	₩7.56 Billion ≈ $5.12 Million	0.117x	-8.46%
2016-12-31	₩60.37 Billion ≈ $40.91 Million	₩7.71 Billion ≈ $5.23 Million	0.128x	-29.41%
2015-12-31	₩54.88 Billion ≈ $37.19 Million	₩9.93 Billion ≈ $6.73 Million	0.181x	+41.03%
2014-12-31	₩51.99 Billion ≈ $35.23 Million	₩6.67 Billion ≈ $4.52 Million	0.128x	--

About Choong Ang Vaccine Laboratory Co. Ltd

KQ:072020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$57.71 Million

₩85.16 Billion KRW

Market Cap Rank

#21465 Global

#1259 in Korea

Share Price

₩9200.00

Change (1 day)

+0.33%

52-Week Range

₩8780.00 - ₩10140.00

All Time High

₩30815.73